51131738 Rocepafant

Definition

UNSPSC 51131738

This classification denotes an antiplatelet agent with the molecular formula C26H23ClN6OS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4KGX1STY2N, chemically known as 6-(o-chlorophenyl)-7,10-dihydro-1-methylthio-4h-pyrido(4,3:4,5)thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine-9(8h)-carboxy-p-anisidide but generally known as rocepafant, which bears US NIH Compound Identifier 3033963. European Medicines Agency schedules Rocepafant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10350MIG. The term ROCEPAFANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). ROCEPAFANT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rocepafant under HS 29349990 and SITC 51579. As of Q4 2014, ROCEPAFANT remains the US FDA Preferred Term for this commodity. Rocepafant bears US NLM identifiers UMLS ID C2347968 and NCI Concept Code C73133. SMILES: CLC1C(C2=NCC3N(C4SC5C(CCN(C5)C(=S)NC5CCC(OC)CC5)C24)C(NN3)C)CCCC1.

Same parent

Under 51131700 · 48

51131701 Abciximab Commodity 51131703 Streptokinase Commodity 51131704 Urokinase Commodity 51131705 Dipyridamole Commodity 51131706 Argatroban Commodity 51131710 Eptifibatide Commodity 51131711 Tenecteplase Commodity 51131714 Anistreplase Commodity 51131716 Reteplase Commodity 51131717 Dacopafant Commodity 51131718 Anagrelide Commodity 51131719 Apafant Commodity 51131720 Benzarone Commodity 51131721 Bepafant Commodity 51131722 Carafiban Commodity 51131723 Cloricromen Commodity 51131724 Midazogrel Commodity 51131725 Epoprostenol or prostacyclin Commodity 51131726 Gantofiban Commodity 51131727 Ifetroban Commodity 51131728 Iliparcil Commodity 51131729 Lamifiban Commodity 51131730 Lotrafiban Commodity 51131731 Setipafant Commodity 51131732 Modipafant Commodity 51131733 Naroparcil Commodity 51131734 Nicogrelate Commodity 51131735 Nupafant Commodity 51131736 Ozagrel Commodity 51131737 Picotamide Commodity 51131738 Rocepafant You are here 51131739 Taprostene Commodity 51131740 Ticagrelor Commodity 51131741 Trifenagrel Commodity 51131742 Triflusal Commodity 51131743 Anagrelide hydrochloride monohydrate Commodity 51131744 Argatroban anhydrous Commodity 51131745 Argatroban monohydrate Commodity 51131746 Cloricromen hydrochloride Commodity 51131747 Epoprostenol sodium Commodity 51131748 Ifetroban sodium Commodity 51131749 Lamifiban hydrochloride Commodity 51131750 Lotrafiban hydrochloride Commodity 51131751 Ozagrel hydrochloride Commodity 51131752 Ozagrel hydrochloride hydrate Commodity 51131753 Ozagrel sodium Commodity 51131754 Taprostene sodium Commodity 51131755 Vorapaxar sulfate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51130000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class